Due to the study sponsor's request to prematurely terminate this study, the numbers of participants enrolled in the study discontinued or some discontinued earlier due to a screening failure.

The purpose of this study is to identify whether the combination of coconut Nourish and Queen Garnet plum are able to attenuate ageing-related complications, including muscle mass loss and inflammation. The study endpoints will measure muscle mass as the primary endpoint with blood lipids, glucose, blood pressure, and inflammatory markers serving as some of the secondary endpoints. As the two products are rich in dietary fibre and anthocyanins, respectively, the study outcome will help to understand role of these dietary components in improving complications that are seen quite frequently in elderly population.

Inclusion Criteria:

• Aged 65 years and above
• Able to give written informed consent
• Able to read, write and speak English
• Body mass index less than or equal to 30 kg/m^2
• Either do not suffer from a chronic disease or, if suffering from a chronic disease, then key parameters (blood pressure, blood lipids concentration and blood glucose concentrations) are within the normal physiological range
• Either take no chronic medication or have been treated with a stable dosage of medication for at least 3 months as confirmed by family physician.
• Either take no supplements, or have been utilizing supplements in a stable and consistent dose for at least 3 months, and plan to continue taking a stable and consistent dose throughout the entire study.

Exclusion Criteria:

• Smokers
• Consumption of more than 2 alcoholic drinks/day, or > 14 alcoholic beverages a week, or history of alcoholism or drug dependence
• Uncontrolled hypertension, recent stroke or myocardial infarction, hypothyroidism, diabetes mellitus or kidney disease
• Major disability or disorder requiring continuous medical attention and treatment such as chronic heart failure, liver disease, renal failure or cancer, chronic infections or major surgery within 6 months prior to randomization
• Despite taking medication, do not have values for key parameters (blood pressure, blood lipids concentration and blood glucose concentrations) within normal physiological ranges
• Fasting glucose ≥ 5.6 mmol/L
• Triglycerides ≥ 1.7 mmol/L
• Systolic and diastolic blood pressures ≥130/85 mmHg
• High-density lipoprotein cholesterol ≤1.0 mmol/L
• Have gained or lost >10 lbs in the previous 3 months, or plan to lose weight at any time during the study
• History of allergy to coconut, plum, plain flour, butter or milk
• Any planned surgeries during the study